Literature DB >> 23246829

VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa.

Zheng-Hao Piao1, Mi Sun Kim, Mira Jeong, Sohyun Yun, Suk Hyung Lee, Hu-Nan Sun, Hae Young Song, Hyun-Woo Suh, Haiyoung Jung, Suk Ran Yoon, Tae-Don Kim, Young-Ho Lee, Inpyo Choi.   

Abstract

Vitamin-D3 upregulated protein-1 (VDUP1) is a stress response protein. Pseudomonas aeruginosa (P. aeruginosa) infection is a leading cause of death. Mice infected with live P. aeruginosa exhibit significantly decreased VDUP1 expression. However, the function of VDUP1 during P. aeruginosa-induced mouse bacteremic shock is unknown. To address the function of VDUP1 in P. aeruginosa-infected mice, we constructed a bacteremic shock model wherein both wild-type and VDUP1-deficient mice were infected intra-peritoneally with live P. aeruginosa. We found that VDUP1-deficient mice were more resistant to P. aeruginosa-induced bacteremic shock than wild-type mice, as shown by the increased survival, accelerated bacterial clearance and suppression of cytokine overproduction of the VDUP1-deficient mice. VDUP1 promoted the recruitment of neutrophils into the peritoneal cavities of infected mice. VDUP1 impeded the phagocytosis of non-opsonized P. aeruginosa via phosphatidylinositide 3-kinase (PI3K) pathway in macrophages. P. aeruginosa infection induced the generation of reactive oxygen species (ROS), and the increased production of ROS by the peritoneal cells of VDUP1-deficient mice was advantageous in clearing the bacteria. Overall, VDUP1 aggravates bacteremic shock; thus, VDUP1 can be considered a target molecule for the inhibition of P. aeruginosa-induced bacteremic shock.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246829     DOI: 10.1016/j.cellimm.2012.11.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

2.  Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.

Authors:  Xue-Qing Zhang; Orli Even-Or; Xiaoyang Xu; Mariska van Rosmalen; Lucas Lim; Suresh Gadde; Omid C Farokhzad; Edward A Fisher
Journal:  Adv Healthc Mater       Date:  2014-08-22       Impact factor: 9.933

3.  Development of therapeutic polymeric nanoparticles for the resolution of inflammation.

Authors:  Suresh Gadde; Orli Even-Or; Nazila Kamaly; Apoorva Hasija; Philippe G Gagnon; Krishna H Adusumilli; Andrea Erakovic; Anoop K Pal; Xue-Qing Zhang; Nagesh Kolishetti; Jinjun Shi; Edward A Fisher; Omid C Farokhzad
Journal:  Adv Healthc Mater       Date:  2014-03-24       Impact factor: 9.933

4.  Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma.

Authors:  Joseph A DiDonato; Ying Huang; Kulwant S Aulak; Orli Even-Or; Gary Gerstenecker; Valentin Gogonea; Yuping Wu; Paul L Fox; W H Wilson Tang; Edward F Plow; Jonathan D Smith; Edward A Fisher; Stanley L Hazen
Journal:  Circulation       Date:  2013-08-22       Impact factor: 29.690

Review 5.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

6.  HECT E3 Ubiquitin Ligase-Regulated Txnip Degradation Facilitates TLR2-Mediated Inflammation During Group A Streptococcal Infection.

Authors:  Po-Chun Tseng; Chih-Feng Kuo; Miao-Huei Cheng; Shu-Wen Wan; Chiou-Feng Lin; Chih-Peng Chang; Yee-Shin Lin; Jiunn-Jong Wu; Chi-Chen Huang; Chia-Ling Chen
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.